Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The investigators propose to study the efficacy and safety of nab-Paclitaxel in a Phase II
trial of patients with locally advanced or metastatic adenocarcinomas of the stomach and
gastro-esophageal junction